Back to Search
Start Over
Antioxidant and antidiabetic flavonoids from the leaves of Dypsis pembana (H.E.Moore) Beentje & J.Dransf., Arecaceae: in vitro and molecular docking studies.
- Source :
-
BMC complementary medicine and therapies [BMC Complement Med Ther] 2023 Dec 05; Vol. 23 (1), pp. 440. Date of Electronic Publication: 2023 Dec 05. - Publication Year :
- 2023
-
Abstract
- Background: Oxidative stress and diabetes are medical conditions that have a growing prevalence worldwide, significantly impacting our bodies. Thus, it is essential to develop new natural antioxidant and antidiabetic agents. Dypsis pembana (H.E.Moore) Beentje & J.Dransf (DP) is an ornamental palm of the family Arecaceae. This study aimed to broaden the understanding of this plant's biological properties by evaluating its in vitro antioxidant and antidiabetic activities.<br />Methods: The in vitro antioxidant activities of the crude extract, fractions, and selected isolates were evaluated by DPPH method. While the in vitro antidiabetic activities of these samples were evaluated by assessing the degree of inhibition of α-glucosidase. Additionally, molecular docking analysis was performed to investigate the interactions of tested compounds with two potential targets, the cytochrome c peroxidase and alpha glucosidase.<br />Results: The crude extract displayed the highest antioxidant activity (IC <subscript>50</subscript> of 11.56 µg/ml), whereas among the fractions, the EtOAc fraction was the most potent (IC <subscript>50</subscript> of 14.20 µg/ml). Among tested compounds, isoquercetrin (10) demonstrated the highest potency, with an IC <subscript>50</subscript> value of 3.30 µg/ml, followed by rutin (8) (IC <subscript>50</subscript> of 3.61 µg/ml). Regarding antidiabetic activity, the EtOAc (IC <subscript>50</subscript> of 60.4 µg/ml) and CH <subscript>2</subscript> Cl <subscript>2</subscript> fractions (IC <subscript>50</subscript> of 214.9 µg/ml) showed activity, while the other fractions did not demonstrate significant antidiabetic effects. Among tested compounds, kaempferol-3-O-neohesperidoside (9) showed the highest antidiabetic activity, with an IC <subscript>50</subscript> value of 18.38 µg/ml, followed by kaempferol (4) (IC <subscript>50</subscript> of 37.19 µg/ml). These experimental findings were further supported by molecular docking analysis, which revealed that isoquercetrin and kaempferol-3-O-neohesperidoside exhibited strong enzyme-binding affinities to the studied enzyme targets. This analysis provided insights into the structure-activity relationships among the investigated flavonol-O-glycosides.<br />Conclusion: The biological and computational findings revealed that isoquercetrin and kaempferol-3-O-neohesperidoside have potential as lead compounds for inhibiting cytochrome c peroxidase and alpha glucosidase enzymes, respectively.<br /> (© 2023. The Author(s).)
- Subjects :
- Hypoglycemic Agents pharmacology
Hypoglycemic Agents chemistry
Antioxidants chemistry
Kaempferols
Molecular Docking Simulation
Glycoside Hydrolase Inhibitors pharmacology
Glycoside Hydrolase Inhibitors chemistry
Plant Extracts chemistry
Flavonoids chemistry
alpha-Glucosidases chemistry
Arecaceae
Cytochrome-c Peroxidase
Subjects
Details
- Language :
- English
- ISSN :
- 2662-7671
- Volume :
- 23
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- BMC complementary medicine and therapies
- Publication Type :
- Academic Journal
- Accession number :
- 38053195
- Full Text :
- https://doi.org/10.1186/s12906-023-04287-z